摘要
Soluble beta-amyloid (A尾) oligomers are considered to putatively play a critical role in the early synapse loss and cognitive impairment observed in Alzheimer's disease. We previously demonstrated that A尾 oligomers activate cytosolic phospholipase A<sub>2sub> (cPLA<sub>2sub>), which specifically releases arachidonic acid from membrane phospholipids. We here observed that cPLA<sub>2sub> gene inactivation prevented the alterations of cognitive abilities and the reduction of hippocampal synaptic markers levels noticed upon a single intracerebroventricular injection of A尾 oligomers in wild type mice. We further demonstrated that the A尾 oligomer-induced sphingomyelinase activation was suppressed and that phosphorylation of Akt/protein kinase B (PKB) was preserved in neuronal cells isolated from cPLA<sub>2sub><sup>鈭?鈭?/sup> mice. Interestingly, expression of the A尾 precursor protein (APP) was reduced in hippocampus homogenates and neuronal cells from cPLA<sub>2sub><sup>鈭?鈭?/sup> mice, but the relationship with the resistance of these mice to the A尾 oligomer toxicity requires further investigation. These results therefore show that cPLA<sub>2sub> plays a key role in the A尾 oligomer-associated neurodegeneration, and as such represents a potential therapeutic target for the treatment of Alzheimer's disease.